Artículos por temáticas

CSF phospho-tau levels at Parkinson's disease onset predict the risk for development of motor complications

Bissacco J, Di Lazzaro G, Bovenzi R, Sancesario GM, Conti M, Simonetta C, Mascioli D, Mancini M, Buttarazzi V, Pierantozzi M, Pieri M, Bernardini S, Stefani A, Bentivoglio AR, Calabresi P, Mercuri NB,

J Neurol. 2025 Aug 13;272(9):573. doi: 10.1007/s00415-025-13325-4.

A personalised, gait training telerehabilitation programme for people with Parkinson's Disease: A long-term pilot study

Lopane G, D'Ascanio I, Corzani M, Petrone V, Calandra-Buonaura G, La Porta F, Cortelli P, Gazit E, Brozgol M, Thumm Cornejo P, Giladi N, Ferrari A, Tacconi C, Chiari L, Palmerini L, Hausdorff JM.

Clin Rehabil. 2025 Aug;39(8):1034-1047. doi: 10.1177/02692155251355880. Epub 2025 Jul 14.

An Overview of the Role of Medicinal Plants in Parkinson's Disease: A Semi-Systematic Review

Haxhiu H, Hoxha M, Zela I, Zappacosta B.

Biomedicines. 2025 Aug 18;13(8):2008. doi: 10.3390/biomedicines13082008.

New perspectives on molecular mechanisms underlying exercise-induced benefits in Parkinson's disease

Chen X, Zhang G, Liu M, He J, Zhang Z.

NPJ Parkinsons Dis. 2025 Aug 23;11(1):256. doi: 10.1038/s41531-025-01113-w.

Correction to "Cognitive impairment and dementia in Latin American individuals with parkinsonism and Parkinson's disease: A 10/66 Dementia Research Group study"

Alzheimers Dement. 2025 Aug;21(8):e70599. doi: 10.1002/alz.70599.

Positron Emission Tomography Imaging in Clinical Trials for Parkinson's Disease: Applications of Metabolic Brain Network Approach

Dhawan V, Peng S, Spetsieris PG, Eidelberg D, Ma Y.

Mov Disord. 2025 Aug;40(8):1511-1527. doi: 10.1002/mds.30231. Epub 2025 May 29.

Clinical Insight on "Association Between Stress Hyperglycemia Ratio and Parkinson's Disease Across Different Glucose Metabolism Statuses-A Prospective Study From UK Biobank"

Nizami HA, Khan NEM, Irshad NUN.

Eur J Neurol. 2025 Aug;32(8):e70340. doi: 10.1111/ene.70340.

Effects of Aerobic Exercise on Depressive Symptoms in People with Parkinson's Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Ren H, Zhou Y, Lv Y, Liu X, He L, Yu L.

Brain Sci. 2025 Jul 25;15(8):792. doi: 10.3390/brainsci15080792.

Gender-specific cardiovascular autonomic responses in Parkinson's disease: Insights from an observational study

Meksi K, Garasto E, Bovenzi R, Mercuri NB, Stefani A, Rocchi C.

Parkinsonism Relat Disord. 2025 Aug;137:107902. doi: 10.1016/j.parkreldis.2025.107902. Epub 2025 Jun 4.

Protein regulatory network mediated by palmitoylation modifications in the pathological progression of Parkinson's disease: a narrative review

Liu J, Wang S, Fan L, Zhou X, Zhang S, Wang Q, Dong P, Yu B.

Front Immunol. 2025 Jul 9;16:1615001. doi: 10.3389/fimmu.2025.1615001. eCollection 2025.

Genotype-phenotype association study conducted on LARGE-PD reveals novel loci associated with Parkinson's Disease

Leal TP, Waldo E, Duarte-Zambrano F, Inca-Martinez M, Ramchandra J, Chaparro-Solano HM, Anello AE, Borda V, Gouveia MH, Teixeira-Dos-Santos D, Reyes-Pérez P, Gatto EM, Santos-Lobato BL, Eufraseo G, Le

medRxiv [Preprint]. 2025 Jul 18:2025.07.18.25331793. doi: 10.1101/2025.07.18.25331793.

Regulation of BBB function and pathological evolution of PD by microenvironment "spatiotemporal gradient": unique advantages of microfluidic chips

Yu S, Jiang L, Song M, Yang T, Yuan M, Chen X, Shu H.

Front Aging Neurosci. 2025 Jul 9;17:1599509. doi: 10.3389/fnagi.2025.1599509. eCollection 2025.

Multiomics Integration of Parkinson's Disease Datasets Reveals Unexpected Roles of IRE1 in Its Pathology

Pasat BA, Moncan M, Pilalis E, Samali A, Chatziioannou A, Gorman AM.

Int J Mol Sci. 2025 Jul 12;26(14):6711. doi: 10.3390/ijms26146711.

Use of and Barriers to Subcutaneous Apomorphine Pen Injections in Parkinson's Disease: A Survey by the French NS-PARK Network

Aubignat M, Khelifi F, Rascol O; NS‐PARK/FCRIN Network.

Mov Disord Clin Pract. 2025 Aug;12(8):1211-1213. doi: 10.1002/mdc3.70074. Epub 2025 Apr 9.

Customizing Parkinson's care: sustaining continuous levodopa therapy post-gastrectomy

Buonocore J, Ammendola M, Romano R, Morelli M, Gambardella A.

Neurol Sci. 2025 Jul;46(7):3315-3317. doi: 10.1007/s10072-025-08042-9. Epub 2025 Feb 13.